Earnings Feed
Start Free
Home/Filings/4/0001181431-11-030075
4//SEC Filing

Spagnardi Joseph M 4

Accession 0001181431-11-030075

CIK 0001040416other
View on SEC.govCompany Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 5:07 PM ET

Size

56.0 KB

Accession

0001181431-11-030075

Insider Transaction Report

Form 4
Period: 2011-05-13
INSPIRE PHARMACEUTICALS INCISPH
Spagnardi Joseph M
Senior VP, GC & Secretary
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−10,250→ 0 total
    Exercise: $6.10Exp: 2014-11-12→ Common Stock (10,250 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−22,000→ 0 total
    Exercise: $6.08Exp: 2017-03-17→ Common Stock (22,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−10,250→ 0 total
    Exercise: $5.10Exp: 2016-11-10→ Common Stock (10,250 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−10,250→ 0 total
    Exercise: $3.84Exp: 2016-05-13→ Common Stock (10,250 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−10,250→ 0 total
    Exercise: $3.78Exp: 2015-11-03→ Common Stock (10,250 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−20,500→ 0 total
    Exercise: $5.00Exp: 2013-08-29→ Common Stock (20,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−5,000→ 0 total
    Exercise: $5.25Exp: 2013-01-18→ Common Stock (5,000 underlying)
  • Disposition to Issuer

    Common Stock

    2011-05-13$5.00/sh−20,000$100,000→ 0 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−24,000→ 0 total
    Exercise: $4.80Exp: 2017-08-10→ Common Stock (24,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−22,000→ 0 total
    Exercise: $6.50Exp: 2017-05-11→ Common Stock (22,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−24,000→ 0 total
    Exercise: $7.07Exp: 2017-11-09→ Common Stock (24,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−10,250→ 0 total
    Exercise: $3.79Exp: 2016-03-17→ Common Stock (10,250 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2011-05-13−2,400→ 0 total
    → Common Stock (2,400 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−10,250→ 0 total
    Exercise: $4.55Exp: 2016-08-10→ Common Stock (10,250 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−12,000→ 0 total
    Exercise: $3.49Exp: 2015-05-14→ Common Stock (12,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−10,250→ 0 total
    Exercise: $3.98Exp: 2015-03-19→ Common Stock (10,250 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−10,250→ 0 total
    Exercise: $5.81Exp: 2014-08-14→ Common Stock (10,250 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−10,250→ 0 total
    Exercise: $6.49Exp: 2014-03-20→ Common Stock (10,250 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2011-05-13−2,400→ 0 total
    → Common Stock (2,400 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2011-05-13−2,200→ 0 total
    → Common Stock (2,200 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−7,000→ 0 total
    Exercise: $4.85Exp: 2013-05-03→ Common Stock (7,000 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2011-05-13−19,220→ 0 total
    → Common Stock (19,220 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−10,250→ 0 total
    Exercise: $4.44Exp: 2015-08-13→ Common Stock (10,250 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−10,250→ 0 total
    Exercise: $6.35Exp: 2014-05-14→ Common Stock (10,250 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2011-05-13−2,200→ 0 total
    → Common Stock (2,200 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2011-05-13−35,000→ 0 total
    Exercise: $6.90Exp: 2015-05-05→ Common Stock (35,000 underlying)
Footnotes (3)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated as of April 5, 2011, by and among, Merck & Co., Inc., Monarch Transaction Corp. and Inspire Pharmaceuticals, Inc. (the "Merger Agreement"), these restricted stock units ("RSUs"), whether or not vested, were fully vested immediately prior to and cancelled immediately following the acceptance time under the Merger Agreement in exchange for the right to receive cash payment for each such RSU of $5.00, net to the seller in cash, without interest and less any required withholding taxes.
  • [F2]These stock options were cancelled in accordance with the Merger Agreement. As the exercise price of the options was at or above $5.00, no cash payment was provided.
  • [F3]These stock options were cancelled in accordance with the Merger Agreement in exchange for the right to receive cash payment in accordance with the Merger Agreement. The cash payment for each such option equals the product of (x) the number of shares issuable upon the exercise of such option multiplied by (y) the excess of $5.00 over the exercise price per share for each such option, without interest subject to any required withholding of taxes and the exercise price of such option.

Documents

1 file

Issuer

INSPIRE PHARMACEUTICALS INC

CIK 0001040416

→
Entity typeother

Related Parties

1
  • filerCIK 0001353824

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:07 PM ET
Size
56.0 KB
View on SEC.gov